What predicts response to MTX in RA? 👉🏼DAS28-ESR 👉🏼RA duration 👉🏼Pt global assessment 👉🏼Swollen joint count Abs#1227 #ACR21 @RheumNow https://t.co/s942zvFiZ1

• Clinical Predictors of Response to Methotrexate in Patients with Rheumatoid Art…

Plenary Abs#1428 #ACR21 👉🏼Long-term #steroid use is common in RA incl in pts with high risk of #MACE 👉🏼30days of steroids ➡️ 15% increased odds of MACE @RheumNow https://t.co/fCM3m04ruS https://t.co/FWGmAatYu5

• Association Between Ongoing Glucocorticoid Use and Major Adverse Cardiovascular…

26K Veterans data with RA #ACR21 plenary abst#1428 30 days on glucocorticoids - ⬆️15% odds of Major Adverse Cardiovascular events @RheumNow @BethIWallace https://t.co/BOram4o2rp

Role of GC on MACE in RA: US database analysis 26000+pts 23% on GC >90d/6mo Each 30days of GC dispensed ⏭15% increase in odds of MACE in the following 6month period! Adjustment on several confounders but not disease activity. #Abts1428 #ACR21 @RheumNow https://t.co/prdA7D5fLz https://t.co/F3wCcRAfuf

• Association Between Ongoing Glucocorticoid Use and Major Adverse Cardiovascular…

Plenary Abs#1427 #ACR21 👉🏼#Statins assoc w/ reduced #CVD & all-cause mortality, outweighing modest #T2DM risk increase in RA pts 👉🏼Reduction in all-cause mortality greater in RA than gen population 👉🏼Incr in T2DM risk is NOT greater in RA compared to gen population @RheumNow https://t.co/WcF11B0C2s

Statins in RA - plenary at #ACR21 UK Clinical Practice Research Datalink 1989-2018 @RheumNow Reduction in CVD risk, All cause mortality INCREASE in Type 2 DM risk🧐 - need to make sure we look into it for RA patients! Great work @UNMC_Rheum by Gulsen Ozen! https://t.co/YmTO0xcdjj

RA and CVD: take your statins! Obs UK study Statins ⬇️CVD HR=0.46 ⬇️All cause death HR=0.68 w/ mild ⬆️ T2DM risk HR=1.33 (but not more than in general population) ⭐️NNT to prevent CVD 102 ⭐️NNT to prevent death 46 ⭐️NNH 127 #ACR21 #Abst1427 @RheumNow https://t.co/v6TinuklNv https://t.co/r0rD4jMmuh

• Reduction of Cardiovascular Disease and Mortality versus Risk of New Onset Diab…